Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Macrophage Activation Syndrome

• Ruxolitinib and Methylprednisolone as a First-line Treatment for Macrophage Activation Syndrome
• Evaluate Efficacy, Safety and Tolerability, PK and PD, of Emapalumab in Children and Adults With MAS in Still's or SLE
• Personalised Immunotherapy for SARS-CoV-2 (COVID-19) Associated With Organ Dysfunction
• A Trial of Validation and Restoration of Immune Dysfunction in Severe Infections and Sepsis
• A Study to Investigate the Safety and Efficacy of Emapalumab, an Anti-IFN-gamma mAb in Patients With Systemic Juvenile Idiopathic Arthritis (sJIA) or Adult-onset Still's Disease (AOSD) Developing Macrophage Activation Syndrome/Secondary HLH (MAS/sHL
• Treatment of Macrophage Activation Syndrome (MAS) With Anakinra
• Low-dose IL-2 ( Interleukin-2) Treatment in Macrophage Activation Syndrome（MAS）